LPA genetic variation is associated with type 2 diabetes after adjustment for lipoprotein(a) concentration: results of the Aragon Workers’ health study

Cardiovascular Diabetology · Published 2026-08-03 · DOI 10.1186/s12933-026-03301-1

Free full text

Authors (8)

Pablo M. Corredoira, Daniel Bello Álvarez, Itziar Lamiquiz Moneo, Victoria Marco Benedí, Estíbaliz Jarauta, Martín Laclaustra, Fernando Civeira, Ana Cenarro

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Corredoira, P., Álvarez, D., Moneo, I., et al. (2026). LPA genetic variation is associated with type 2 diabetes after adjustment for lipoprotein(a) concentration: results of the Aragon Workers’ health study. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-026-03301-1

Related articles

• Treatment with dapagliflozin and empagliflozin reduces concentrations of N4-acetylcytidine in plasma, a biomarker associated with vascular damage · Cardiovascular Diabetology · 2026 · Same journal
• Associations of cumulative exposure and dynamic trajectories of the cholesterol–HDL–glucose index and its obesity-related derivatives with cardiovascular disease: a nationwide prospective cohort study · Cardiovascular Diabetology · 2026 · Same journal
• Deep learning analysis of ECGs detects Cardiovascular–Kidney–Metabolic syndrome burden in people with diabetes: a report from the Silesia Diabetes-Heart Project · Cardiovascular Diabetology · 2026 · Same journal
• Predicting all-cause and cardiovascular mortality in hypertensive patients by combining the CHG index and its obesity indicators: a prospective cohort study with survival prediction model · Cardiovascular Diabetology · 2026 · Same journal
• Divergent mitochondrial and fibrotic signatures in atrial fibrillation: insights from organoids and GEO data · Cardiovascular Diabetology · 2026 · Same journal
• STIM1-mediated Treg instability in HFpEF: a new immunological target emerges? · Cardiovascular Diabetology · 2026 · Same journal
• Joint longitudinal trajectories of the triglyceride-glucose index combined with BMI and waist-to-height ratio and incident cardiovascular disease: a prospective cohort study from the English longitudinal study of ageing · Cardiovascular Diabetology · 2026 · Same journal
• Genetically proxied glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor pathway modulation is associated with favorable aging phenotypes: a drug-target Mendelian randomization study · Cardiovascular Diabetology · 2026 · Same journal
• Predictive significance of triglyceride-glucose index in forecasting adverse cardiovascular events among Type 2 diabetes mellitus patients with co-existing metabolic dysfunction-associated steatotic liver disease (MASLD): evidence from two cohort studies · Cardiovascular Diabetology · 2026 · Same journal
• Baseline, repeated-measure burden, and two-time-point patterns of the triglyceride-glucose index-visceral lipid ratio (TyG-VLR) and incident cardiovascular disease in cardiovascular-kidney-metabolic (CKM) syndrome stages 0–3: a longitudinal China Health and Retirement Longitudinal Study (CHARLS) analysis · Cardiovascular Diabetology · 2026 · Same journal